|
US4431657A
(en)
*
|
1982-05-24 |
1984-02-14 |
Ayerst, Mckenna & Harrison Inc. |
Analgesic compositions consisting of 2H-benzothieno[3,2-c]pyrazol-3-amine derivatives
|
|
KR20010086657A
(ko)
*
|
2000-03-02 |
2001-09-15 |
성재갑 |
아미노인다졸 유도체 및 이를 함유하는 싸이클린 의존키나아제 저해제 조성물
|
|
ZA200301701B
(en)
*
|
2000-09-15 |
2004-03-01 |
Vertex Pharma |
Pyrazole compounds useful as protein kinase inhibitors.
|
|
US6660731B2
(en)
|
2000-09-15 |
2003-12-09 |
Vertex Pharmaceuticals Incorporated |
Pyrazole compounds useful as protein kinase inhibitors
|
|
WO2002022605A1
(en)
|
2000-09-15 |
2002-03-21 |
Vertex Pharmaceuticals Incorporated |
Pyrazole compounds useful as protein kinase inhibitors
|
|
SI1318997T1
(sl)
*
|
2000-09-15 |
2006-12-31 |
Vertex Pharma |
Pirazolne spojine, uporabne kot inhibitorji protein-kinaze
|
|
US7473691B2
(en)
*
|
2000-09-15 |
2009-01-06 |
Vertex Pharmaceuticals Incorporated |
Pyrazole compounds useful as protein kinase inhibitors
|
|
US6989385B2
(en)
|
2000-12-21 |
2006-01-24 |
Vertex Pharmaceuticals Incorporated |
Pyrazole compounds useful as protein kinase inhibitors
|
|
KR100406634B1
(ko)
*
|
2001-03-12 |
2003-11-20 |
주식회사 엘지생명과학 |
3,5-디아미노인다졸 유도체, 그의 제조방법 및 사이클린의존성 키나아제 저해제로서의 그의 용도
|
|
BR0212841A
(pt)
|
2001-09-26 |
2004-08-03 |
Pharmacia Italia Spa |
Derivado ativo de aminoindazole como inibidores de cinase, processo para sua preparação e composições farmacêuticas que os contém
|
|
WO2003066629A2
(en)
*
|
2002-02-06 |
2003-08-14 |
Vertex Pharmaceuticals Incorporated |
Heteroaryl compounds useful as inhibitors of gsk-3
|
|
FR2836915B1
(fr)
*
|
2002-03-11 |
2008-01-11 |
Aventis Pharma Sa |
Derives d'aminoindazoles, procede de preparation et intermediaires de ce procede a titre de medicaments et compositions pharmaceutiques les renfermant
|
|
US20040009981A1
(en)
|
2002-03-15 |
2004-01-15 |
David Bebbington |
Compositions useful as inhibitors of protein kinases
|
|
MXPA04011417A
(es)
|
2002-05-17 |
2005-02-14 |
Pharmacia Italia Spa |
Derivados de aminoindazol activos como inhibidores de cinasa, procedimiento para su preparacion y composiciones farmaceuticas que los comprenden.
|
|
MY141867A
(en)
|
2002-06-20 |
2010-07-16 |
Vertex Pharma |
Substituted pyrimidines useful as protein kinase inhibitors
|
|
CN1319968C
(zh)
|
2002-08-02 |
2007-06-06 |
沃泰克斯药物股份有限公司 |
用作gsk－3的抑制剂的吡唑组合物
|
|
WO2004041285A1
(en)
*
|
2002-10-31 |
2004-05-21 |
Amgen Inc. |
Antiinflammation agents
|
|
US7601718B2
(en)
|
2003-02-06 |
2009-10-13 |
Vertex Pharmaceuticals Incorporated |
Compositions useful as inhibitors of protein kinases
|
|
US7592340B2
(en)
*
|
2003-12-04 |
2009-09-22 |
Vertex Pharmaceuticals Incorporated |
Quinoxalines useful as inhibitors of protein kinases
|
|
DE102004005172A1
(de)
*
|
2004-02-02 |
2005-08-18 |
Aventis Pharma Deutschland Gmbh |
Indazolderivate als Inhibitoren der Hormon Sensitiven Lipase
|
|
ATE542814T1
(de)
|
2005-08-18 |
2012-02-15 |
Vertex Pharma |
Pyrazinkinaseinhibitoren
|
|
MX2008005814A
(es)
*
|
2005-11-03 |
2008-10-15 |
Vertex Pharma |
Aminopirimidinas utiles como inhibidores de cinasa.
|
|
ES2385404T3
(es)
*
|
2006-04-14 |
2012-07-24 |
Abbott Laboratories |
Procedimiento para la preparación de ureas de indazolilo que inhiben los receptores vaniloides de subtipo 1 (VR1)
|
|
CA2668429A1
(en)
|
2006-11-02 |
2008-05-15 |
Vertex Pharmaceuticals Incorporated |
Aminopyridines and aminopyrimidines useful as inhibitors of protein kinases
|
|
ES2347721T3
(es)
|
2006-12-19 |
2010-11-03 |
Vertex Pharmaceuticals, Inc. |
Aminopirimidinas utiles como inhibidores de proteina quinasas.
|
|
AU2008226457B2
(en)
|
2007-03-09 |
2014-03-20 |
Vertex Pharmaceuticals Incorporated |
Aminopyrimidines useful as inhibitors of protein kinases
|
|
EP2137183B1
(en)
|
2007-03-09 |
2011-09-28 |
Vertex Pharmaceuticals Incorporated |
Aminopyrimidines useful as inhibitors of protein kinases
|
|
EP2134709A1
(en)
|
2007-03-09 |
2009-12-23 |
Vertex Pharmaceuticals, Inc. |
Aminopyridines useful as inhibitors of protein kinases
|
|
NZ580343A
(en)
|
2007-04-13 |
2012-03-30 |
Vertex Pharma |
Aminopyrimidines useful as kinase inhibitors
|
|
JP5389785B2
(ja)
|
2007-05-02 |
2014-01-15 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
キナーゼ阻害剤として有用なチアゾールおよびピラゾール
|
|
MX2009011811A
(es)
*
|
2007-05-02 |
2010-01-14 |
Vertex Pharma |
Aminopirimidinas utiles como inhibidores de cinasa.
|
|
CA2694381A1
(en)
|
2007-05-02 |
2008-11-13 |
Vertex Pharmaceuticals Incorporated |
Aminopyrimidines useful as kinase inhibitors
|
|
EP2164842A2
(en)
*
|
2007-05-24 |
2010-03-24 |
Vertex Pharmaceuticals Incorporated |
Thiazoles and pyrazoles useful as kinase inhibitors
|
|
NZ582879A
(en)
*
|
2007-07-31 |
2012-03-30 |
Vertex Pharma |
Process for preparing 5-fluoro-1h-pyrazolo [3, 4-b] pyridin-3-amine and derivatives thereof
|
|
MX2011002312A
(es)
*
|
2008-09-03 |
2011-04-26 |
Vertex Pharma |
Co-cristales y formulaciones farmaceuticas que comprenden los mismos.
|
|
DE102009004245A1
(de)
|
2009-01-09 |
2010-07-15 |
Bayer Schering Pharma Aktiengesellschaft |
Neue anellierte, Heteroatom-verbrückte Pyrazol- und Imidazol-Derivate und ihre Verwendung
|
|
WO2014017936A2
(en)
|
2012-07-24 |
2014-01-30 |
Bial- Portela & Ca, S.A. |
Urea compounds and their use as enzyme inhibitors
|
|
JP2015528013A
(ja)
*
|
2012-07-27 |
2015-09-24 |
ビアル−ポルテラ エ コンパニア，ソシエダッド アノニマ |
置換ウレア化合物の合成方法
|
|
AU2014293731B2
(en)
|
2013-07-24 |
2018-03-08 |
Bial - Portela & Ca, S.A. |
Imidazolecarboxamides and their use as FAAH inhibitors
|